Key Points
-
The reversible conjugation of ubiquitin chains to protein substrates regulates almost every cellular process.
-
Ubiquitin chains can be assembled via one of the seven ubiquitin Lys residues (which are Lys6, Lys11, Lys27, Lys29, Lys33, Lys48 or Lys63) or via the amino terminus (Met1). Atypical ubiquitin chains are those not linked via canonical Lys48 linkages or Lys63 linkages.
-
Available structures of ubiquitin chains suggest that each linkage type adopts unique conformations. Ubiquitin-binding domains (UBDs) and deubiquitinases (DUBs) exploit the distinct features of polyubiquitin to achieve specificity.
-
All linkage types coexist in cells, and the abundance of particular atypical linkages changes in response to specific stimuli and can be altered in disease states.
-
The enzymatic assembly of ubiquitin chains requires the action of E1 ubiquitin-activating enzymes, E2 ubiquitin-conjugating enzymes and E3 ubiquitin-ligating enzymes. E2 enzymes and certain classes of E3 ligases determine the chain linkage type.
-
DUBs negatively regulate ubiquitylation by hydrolyzing ubiquitin chains. Although many DUBs are promiscuous, certain DUBs such as members of the ovarian tumour (OTU) family have evolved distinct mechanisms to achieve linkage selectivity.
-
New tools such as the application of chemical biology techniques to achieve site-specific ubiquitylation, the generation of ubiquitin polymers of defined linkage types, linkage-specific antibodies and ubiquitin sensors will advance the field of ubiquitin research.
-
Little is known about the biological roles of atypical ubiquitylation events. The reported physiological roles highlight the fact that the differently linked polyubiquitin chains are independent post-translational modifications.
Abstract
Ubiquitylation is one of the most abundant and versatile post-translational modifications (PTMs) in cells. Its versatility arises from the ability of ubiquitin to form eight structurally and functionally distinct polymers, in which ubiquitin moieties are linked via one of seven Lys residues or the amino terminus. Whereas the roles of Lys48- and Lys63-linked polyubiquitin in protein degradation and cellular signalling are well characterized, the functions of the remaining six 'atypical' ubiquitin chain types (linked via Lys6, Lys11, Lys27, Lys29, Lys33 and Met1) are less well defined. Recent developments provide insights into the mechanisms of ubiquitin chain assembly, recognition and hydrolysis and allow detailed analysis of the functions of atypical ubiquitin chains. The importance of Lys11 linkages and Met1 linkages in cell cycle regulation and nuclear factor-κB activation, respectively, highlight that the different ubiquitin chain types should be considered as functionally independent PTMs.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$189.00 per year
only $15.75 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Ikeda, F. & Dikic, I. Atypical ubiquitin chains: new molecular signals. Protein modifications: beyond the usual suspects review series. EMBO Rep. 9, 536–542 (2008).
Behrends, C. & Harper, J. W. Constructing and decoding unconventional ubiquitin chains. Nature Struct. Mol. Biol. 18, 520–528 (2011).
Komander, D. & Rape, M. The ubiquitin code. Annu. Rev. Biochem. 81, 203–229 (2012).
Dye, B. T. & Schulman, B. A. Structural mechanisms underlying posttranslational modification by ubiquitin-like proteins. Annu. Rev. Biophys. Biomol. Struct. 36, 131–150 (2007).
Winget, J. M. & Mayor, T. The diversity of ubiquitin recognition: hot spots and varied specificity. Mol. Cell 38, 627–635 (2010).
Husnjak, K. & Dikic, I. Ubiquitin-binding proteins: decoders of ubiquitin-mediated cellular functions. Annu. Rev. Biochem. 81, 291–322 (2012).
Reyes-Turcu, F. E., Ventii, K. H. & Wilkinson, K. D. Regulation and cellular roles of ubiquitin-specific deubiquitinating enzymes. Annu. Rev. Biochem. 78, 363–397 (2009).
Komander, D., Clague, M. J. & Urbé, S. Breaking the chains: structure and function of the deubiquitinases. Nature Rev. Mol. Cell Biol. 10, 550–563 (2009).
Chen, Z. J. & Sun, L. J. Nonproteolytic functions of ubiquitin in cell signaling. Mol. Cell 33, 275–286 (2009).
Virdee, S., Ye, Y., Nguyen, D. P., Komander, D. & Chin, J. W. Engineered diubiquitin synthesis reveals Lys29-isopeptide specificity of an OTU deubiquitinase. Nature Chem. Biol. 6, 750–757 (2010).
Bremm, A. & Komander, D. Emerging roles for Lys11-linked polyubiquitin in cellular regulation. Trends Biochem. Sci. 36, 355–363 (2011).
Bremm, A., Freund, S. M. V. & Komander, D. Lys11-linked ubiquitin chains adopt compact conformations and are preferentially hydrolyzed by the deubiquitinase Cezanne. Nature Struct. Mol. Biol. 17, 939–947 (2010).
Matsumoto, M. L. et al. K11-linked polyubiquitination in cell cycle control revealed by a K11 linkage-specific antibody. Mol. Cell 39, 477–484 (2010).
Cook, W. J., Jeffrey, L. C., Carson, M., Chen, Z. & Pickart, C. M. Structure of a diubiquitin conjugate and a model for interaction with ubiquitin conjugating enzyme (E2). J. Biol. Chem. 267, 16467–16471 (1992).
Eddins, M. J., Varadan, R., Fushman, D., Pickart, C. M. & Wolberger, C. Crystal structure and solution NMR studies of Lys48-linked tetraubiquitin at neutral pH. J. Mol. Biol. 367, 204–211 (2007).
Datta, A. B., Hura, G. L. & Wolberger, C. The structure and conformation of Lys63-linked tetraubiquitin. J. Mol. Biol. 392, 1117–1124 (2009).
Komander, D. et al. Molecular discrimination of structurally equivalent Lys 63-linked and linear polyubiquitin chains. EMBO Rep. 10, 466–473 (2009).
Varadan, R., Walker, O., Pickart, C. & Fushman, D. Structural properties of polyubiquitin chains in solution. J. Mol. Biol. 324, 637–647 (2002).
Rohaim, A., Kawasaki, M., Kato, R., Dikic, I. & Wakatsuki, S. Structure of a compact conformation of linear diubiquitin. Acta Crystallogr. D Biol. Crystallogr. 68, 102–108 (2012).
Sloper-Mould, K. E., Jemc, J. C., Pickart, C. M. & Hicke, L. Distinct functional surface regions on ubiquitin. J. Biol. Chem. 276, 30483–30489 (2001).
Chau, V. et al. A multiubiquitin chain is confined to specific lysine in a targeted short-lived protein. Science 243, 1576–1583 (1989).
Finley, D. et al. Inhibition of proteolysis and cell cycle progression in a multiubiquitination-deficient yeast mutant. Mol. Cell. Biol. 14, 5501–5509 (1994).
Xu, P. et al. Quantitative proteomics reveals the function of unconventional ubiquitin chains in proteasomal degradation. Cell 137, 133–145 (2009).
Spence, J., Sadis, S., Haas, A. L. & Finley, D. A ubiquitin mutant with specific defects in DNA repair and multiubiquitination. Mol. Cell. Biol. 15, 1265–1273 (1995). Discovery of Lys63-linked polyubiquitin and first implication of this chain type in DNA repair.
Hofmann, R. M. & Pickart, C. M. Noncanonical MMS2-encoded ubiquitin-conjugating enzyme functions in assembly of novel polyubiquitin chains for DNA repair. Cell 96, 645–653 (1999).
Wang, C. et al. TAK1 is a ubiquitin-dependent kinase of MKK and IKK. Nature 412, 346–351 (2001).
Dammer, E. B. et al. Polyubiquitin linkage profiles in three models of proteolytic stress suggest the etiology of Alzheimer disease. J. Biol. Chem. 286, 10457–10465 (2011).
Ziv, I. et al. A perturbed ubiquitin landscape distinguishes between ubiquitin in trafficking and in proteolysis. Mol. Cell Proteomics 10, M111.009753 (2011).
Wagner, S. A. et al. A proteome-wide, quantitative survey of in vivo ubiquitylation sites reveals widespread regulatory roles. Mol. Cell Proteomics 10, M11.013284 (2011).
Kim, W. et al. Systematic and quantitative assessment of the ubiquitin-modified proteome. Mol. Cell 44, 325–340 (2011). References 23 and 27–30 use mass spectrometry to study the abundance of differently linked ubiquitin polymers in cells.
Bennett, E. J. et al. Global changes to the ubiquitin system in Huntington's disease. Nature 448, 704–708 (2007).
Ye, Y. & Rape, M. Building ubiquitin chains: E2 enzymes at work. Nature Rev. Mol. Cell Biol. 10, 755–764 (2009).
Wenzel, D. M., Stoll, K. E. & Klevit, R. E. E2s: structurally economical and functionally replete. Biochem. J. 433, 31–42 (2010).
Wenzel, D. M., Lissounov, A., Brzovic, P. S. & Klevit, R. E. UBCH7 reactivity profile reveals parkin and HHARI to be RING/HECT hybrids. Nature 474, 105–108 (2011). Elegant biochemical experiments demonstrate that some E2s discharge their ubiquitin exclusively to Cys residues and reveal a thioester intermediate in RBR E3 ligases.
Alpi, A. F., Pace, P. E., Babu, M. M. & Patel, K. J. Mechanistic insight into site-restricted monoubiquitination of FANCD2 by Ube2t, FANCL, and FANCI. Mol. Cell 32, 767–777 (2008).
Longerich, S., San Filippo, J., Liu, D. & Sung, P. FANCI binds branched DNA and is monoubiquitinated by UBE2T–FANCL. J. Biol. Chem. 284, 23182–23186 (2009).
Sato, K., Toda, K., Ishiai, M., Takata, M. & Kurumizaka, H. DNA robustly stimulates FANCD2 monoubiquitylation in the complex with FANCI. Nucleic Acids Res. 40, 4553–4561.
Scaglione, K. M. et al. Ube2w and ataxin-3 coordinately regulate the ubiquitin ligase CHIP. Mol. Cell 43, 599–612 (2011).
Williamson, A. et al. Regulation of ubiquitin chain initiation to control the timing of substrate degradation. Mol. Cell 42, 744–757 (2011).
Jin, L., Williamson, A., Banerjee, S., Philipp, I. & Rape, M. Mechanism of ubiquitin-chain formation by the human anaphase-promoting complex. Cell 133, 653–665 (2008). First report showing that the mammalian APC/C assembles Lys11 linkages, which requires a novel surface on ubiquitin termed the TEK box.
Dynek, J. N. et al. c-IAP1 and UbcH5 promote K11-linked polyubiquitination of RIP1 in TNF signalling. EMBO J. 29, 4198–4209 (2010).
Windheim, M., Peggie, M. & Cohen, P. Two different classes of E2 ubiquitin-conjugating enzymes are required for the mono-ubiquitination of proteins and elongation by polyubiquitin chains with a specific topology. Biochem. J. 409, 723–729 (2008).
Duncan, L. M. et al. Lysine-63-linked ubiquitination is required for endolysosomal degradation of class I molecules. EMBO J. 25, 1635–1645 (2006).
Rodrigo-Brenni, M. C. & Morgan, D. O. Sequential E2s drive polyubiquitin chain assembly on APC targets. Cell 130, 127–139 (2007).
Moraes, T. F. et al. Crystal structure of the human ubiquitin conjugating enzyme complex, hMms2–hUbc13. Nature Struct. Biol. 8, 669–673 (2001).
Wickliffe, K. E., Lorenz, S., Wemmer, D. E., Kuriyan, J. & Rape, M. The mechanism of linkage-specific ubiquitin chain elongation by a single-subunit E2. Cell 144, 769–781 (2011). Shows that the Lys11-specific UBE2S E2 enzyme uses substrate-assisted catalysis to assemble ubiquitin polymers processively.
Eddins, M. J., Carlile, C. M., Gomez, K. M., Pickart, C. M. & Wolberger, C. Mms2–Ubc13 covalently bound to ubiquitin reveals the structural basis of linkage-specific polyubiquitin chain formation. Nature Struct. Mol. Biol. 13, 915–920 (2006). First crystal structure of a ubiquitin ligation machinery poised for catalysis, explaining the Lys63-specificity of the UBE2N–UBE2V2 complex.
David, Y., Ziv, T., Admon, A. & Navon, A. The E2 ubiquitin-conjugating enzymes direct polyubiquitination to preferred lysines. J. Biol. Chem. 285, 8595–8604 (2010).
Rotin, D. & Kumar, S. Physiological functions of the HECT family of ubiquitin ligases. Nature Rev. Mol. Cell Biol. 10, 398–409 (2009).
Kim, H. C. & Huibregtse, J. M. Polyubiquitination by HECT E3s and the determinants of chain type specificity. Mol. Cell. Biol. 29, 3307–3318 (2009).
You, J. & Pickart, C. M. A. HECT domain E3 enzyme assembles novel polyubiquitin chains. J. Biol. Chem. 276, 19871–19878 (2001).
Peng, D. J. et al. Noncanonical K27-linked polyubiquitination of TIEG1 regulates Foxp3 expression and tumor growth. J. Immunol. 186, 5638–5647 (2011).
Huang, H. et al. K33-linked polyubiquitination of T cell receptor-ζ regulates proteolysis-independent T cell signaling. Immunity 33, 60–70 (2010).
Chastagner, P., Israël, A. & Brou, C. Itch/AIP4 mediates deltex degradation through the formation of K29-linked polyubiquitin chains. EMBO Rep. 7, 1147–1153 (2006).
Huang, L. et al. Structure of an E6AP–UbcH7 complex: insights into ubiquitination by the E2–E3 enzyme cascade. Science 286, 1321–1326 (1999).
Kamadurai, H. B. et al. Insights into ubiquitin transfer cascades from a structure of a UbcH5B∼ubiquitin–HECTNEDD4L complex. Mol. Cell 36, 1095–1102 (2009).
French, M. E., Kretzmann, B. R. & Hicke, L. Regulation of the RSP5 uiquitin ligase by an intrinsic ubiquitin-binding site. J. Biol. Chem. 284, 12071–12079 (2009).
Ogunjimi, A. A. et al. The ubiquitin binding region of the Smurf HECT domain facilitates polyubiquitylation and binding of ubiquitylated substrates. J. Biol. Chem. 285, 6308–6315 (2010).
Kim, H. C., Steffen, A. M., Oldham, M. L., Chen, J. & Huibregtse, J. M. Structure and function of a HECT domain ubiquitin-binding site. EMBO Rep. 12, 334–341 (2011).
Maspero, E. et al. Structure of the HECT:ubiquitin complex and its role in ubiquitin chain elongation. EMBO Rep. 12, 342–349 (2011). Reveals, together with references 56 and 59, two binding sites for ubiquitin on NEDD4 family HECT domains.
Eisenhaber, B., Chumak, N., Eisenhaber, F. & Hauser, M.-T. The ring between ring fingers (RBR) protein family. Genome Biol. 8, 209 (2007).
Youle, R. J. & Narendra, D. P. Mechanisms of mitophagy. Nature Rev. Mol. Cell Biol. 12, 9–14 (2011).
Tokunaga, F. & Iwai, K. LUBAC, a novel ubiquitin ligase for linear ubiquitination, is crucial for inflammation and immune responses. Microbes Infect. 14, 563–572 (2012).
Kirisako, T. et al. A ubiquitin ligase complex assembles linear polyubiquitin chains. EMBO J. 25, 4877–4887 (2006). Identification and biochemical characterization of LUBAC, the linear ubiquitin chain assembly complex.
Deshaies, R. J. & Joazeiro, C. A. RING domain E3 ubiquitin ligases. Annu. Rev. Biochem. 78, 399–434 (2009).
Hatakeyama, S. TRIM proteins and cancer. Nature Rev. Cancer 11, 792–804 (2011).
Clague, M. J., Coulson, J. M. & Urbe, S. Cellular functions of the DUBs. J. Cell Sci. 125, 277–286 (2012).
Shanmugham, A. & Ovaa, H. DUBs and disease: activity assays for inhibitor development. 11, 688–696 (2008).
Cohen, P. & Tcherpakov, M. Will the ubiquitin system furnish as many drug targets as protein kinases? Cell 143, 686–693 (2010).
Faesen, A. C. et al. The differential modulation of USP activity by internal regulatory domains, interactors and eight ubiquitin chain types. 18, 1550–1561 (2011).
Sato, Y. et al. Structural basis for specific cleavage of Lys 63-linked polyubiquitin chains. Nature 455, 358–362 (2008).
Cooper, E. M. et al. K63-specific deubiquitination by two JAMM/MPN+ complexes: BRISC-associated Brcc36 and proteasomal Poh1. EMBO J. 28, 621–631 (2009).
Popp, M. W., Artavanis-Tsakonas, K. & Ploegh, H. L. Substrate filtering by the active site crossover loop in UCHL3 revealed by sortagging and gain-of-function mutations. J. Biol. Chem. 284, 3593–3602 (2009).
Licchesi, J. D. F. et al. An ankyrin-repeat ubiquitin-binding domain determines TRABID's specificity for atypical ubiquitin chains. Nature Struct. Mol. Biol. 19, 62–71 (2011). Reveals the molecular basis for atypical chain cleavage by TRABID and identifies sites of accumulation of Lys29 and Lys33 chains in cells.
Edelmann, M. J. et al. Structural basis and specificity of human otubain 1-mediated deubiquitination. Biochem. J. 418, 379–390 (2009).
Tran, H., Hamada, F., Schwarz-Romond, T. & Bienz, M. Trabid, a new positive regulator of Wnt-induced transcription with preference for binding and cleaving K63-linked ubiquitin chains. Genes Dev. 22, 528–542 (2008).
Wiener, R., Zhang, X., Wang, T. & Wolberger, C. The mechanism of OTUB1-mediated inhibition of ubiquitination. Nature 483, 618–622 (2012).
Juang, Y.-C. et al. OTUB1 co-opts Lys48-linked ubiquitin recognition to suppress E2 enzyme function. Mol. Cell 45, 384–397 (2012). References 77 and 78 reveal the mechanisms of Lys48 specificity of OTUB and its mechanism to inhibit E2 enzymes and hence ubiquitin chain assembly.
Boname, J. M. et al. Efficient internalization of MHC I requires lysine-11 and lysine-63 mixed linkage polyubiquitin chains. Traffic 11, 210–220 (2010).
Iwai, K. & Tokunaga, F. Linear polyubiquitination: a new regulator of NF-κB activation. EMBO Rep. 10, 706–713 (2009).
Wickliffe, K., Williamson, A., Jin, L. & Rape, M. The multiple layers of ubiquitin-dependent cell cycle control. Chem. Rev. 109, 1537–1548 (2009).
Wu-Baer, F., Lagrazon, K., Yuan, W. & Baer, R. The BRCA1/BARD1 heterodimer assembles polyubiquitin chains through an unconventional linkage involving lysine residue K6 of ubiquitin. J. Biol. Chem. 278, 34743–34746 (2003).
Nishikawa, H. et al. Mass spectrometric and mutational analyses reveal Lys-6-linked polyubiquitin chains catalyzed by BRCA1-BARD1 ubiquitin ligase. J. Biol. Chem. 279, 3916–3924 (2004).
Morris, J. R. & Solomon, E. BRCA1:BARD1 induces the formation of conjugated ubiquitin structures, dependent on K6 of ubiquitin, in cells during DNA replication and repair. Hum. Mol. Genet. 13, 807–817 (2004).
Sato, K. Nucleophosmin/B23 is a candidate substrate for the BRCA1–BARD1 ubiquitin ligase. J. Biol. Chem. 279, 30919–30922 (2004).
Yu, X. BRCA1 ubiquitinates its phosphorylation-dependent binding partner CtIP. Genes Dev. 20, 1721–1726 (2006).
Wu, W. et al. BRCA1 ubiquitinates RPB8 in response to DNA damage. Cancer Res. 67, 951–958 (2007).
Sobhian, B. et al. RAP80 targets BRCA1 to specific ubiquitin structures at DNA damage sites. Science 316, 1198–1202 (2007).
Wu-Baer, F., Ludwig, T. & Baer, R. The UBXN1 protein associates with autoubiquitinated forms of the BRCA1tumor suppressor and inhibits its enzymatic function. Mol. Cell. Biol. 30, 2787–2798 (2010).
Wickliffe, K. E., Williamson, A., Meyer, H.-J., Kelly, A. & Rape, M. K11-linked ubiquitin chains as novel regulators of cell division. Trends Cell Biol. 21, 656–663 (2011).
Williamson, A. et al. Identification of a physiological E2 module for the human anaphase-promoting complex. Proc. Natl Acad. Sci. USA 106, 18213–18218 (2009).
Pareja, F. et al. Deubiquitination of EGFR by Cezanne-1 contributes to cancer progression. Oncogene 19 Dec 2011 (doi:10.1038/onc.2011.587).
Goto, E. et al. Contribution of lysine 11-linked ubiquitination to MIR2-mediated major histocompatibility complex class I internalization. J. Biol. Chem. 285, 35311–35319 (2010).
Glauser, L., Sonnay, S., Stafa, K. & Moore, D. J. Parkin promotes the ubiquitination and degradation of the mitochondrial fusion factor mitofusin 1. J. Neurochem. 118, 636–645 (2011).
Geisler, S. et al. PINK1/Parkin-mediated mitophagy is dependent on VDAC1 and p62/SQSTM1. Nature Cell Biol. 12, 119–131 (2010). Shows that parkin assembles Lys27 linkages on itself and on its substrates.
Durcan, T. M. et al. The Machado–Joseph disease-associated mutant form of ataxin-3 regulates parkin ubiquitination and stability. Hum. Mol. Genet. 20, 141–154 (2010).
Al-Hakim, A. K. et al. Control of AMPK-related kinases by USP9X and atypical Lys29/Lys33-linked polyubiquitin chains. Biochem. J. 411, 249–260 (2008).
Hay-Koren, A., Caspi, M., Zilberberg, A. & Rosin-Arbesfeld, R. The EDD E3 ubiquitin ligase ubiquitinates and up-regulates beta-catenin. Mol. Biol. Cell 22, 399–411 (2011).
Ohshima, R. et al. Putative tumor suppressor EDD interacts with and up-regulates APC. Genes Cells 12, 1339–1345 (2007).
Metzger, M. B. & Weissman, A. M. Working on a chain: E3s ganging up for ubiquitylation. Nature Cell Biol. 12, 1124–1126 (2010).
Hwang, C.-S., Shemorry, A., Auerbach, D. & Varshavsky, A. The N-end rule pathway is mediated by a complex of the RING-type Ubr1 and HECT-type Ufd4 ubiquitin ligases. Nature Cell Biol. 12, 1177–1185 (2010).
Koegl, M. et al. A novel ubiquitination factor, E4, is involved in multiubiquitin chain assembly. Cell 96, 635–644 (1999).
Locksley, R. M., Killeen, N. & Lenardo, M. J. The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell 104, 487–501 (2001).
Wertz, I. E. & Dixit, V. M. Regulation of death receptor signaling by the ubiquitin system. Cell Death Differ. 17, 14–24 (2010).
Skaug, B., Jiang, X. & Chen, Z. J. The role of ubiquitin in NF-κB regulatory pathways. Annu. Rev. Biochem. 78, 769–796 (2009).
Xu, M., Skaug, B., Zeng, W. & Chen, Z. J. A ubiquitin replacement strategy in human cells reveals distinct mechanisms of IKK activation by TNFα and IL-1β. Mol. Cell 36, 302–314 (2009).
Yamamoto, M. et al. Key function for the Ubc13 E2 ubiquitin-conjugating enzyme in immune receptor signaling. Nature Immunol. 7, 962–970 (2006).
Zotti, T. et al. TRAF7 protein promotes Lys-29-linked polyubiquitination of IκB kinase (IKKγ)/NF-κB essential modulator (NEMO) and p65/RelA protein and represses NF-κB activation. J. Biol. Chem. 286, 22924–22933 (2011).
Tokunaga, F. et al. SHARPIN is a component of the NF-κB-activating linear ubiquitin chain assembly complex. Nature 471, 633–636 (2011).
Gerlach, B. et al. Linear ubiquitination prevents inflammation and regulates immune signalling. Nature 471, 591–596 (2011).
Ikeda, F. et al. SHARPIN forms a linear ubiquitin ligase complex regulating NF-κB activity and apoptosis. Nature 471, 637–641 (2011). References 109, 110 and 111 identify sharpin as a component of LUBAC and provide genetic evidence for the importance of linear chains in TNFα signalling.
Haas, T. L. et al. Recruitment of the linear ubiquitin chain assembly complex stabilizes the TNF-R1 signaling complex and is required for TNF-mediated gene induction. Mol. Cell 36, 831–844 (2009). Identifies LUBAC as an endogenous component of the TNFR complex.
Seymour, R. E. et al. Spontaneous mutations in the mouse Sharpin gene result in multiorgan inflammation, immune system dysregulation and dermatitis. Genes Immun. 8, 416–421 (2007).
Kanayama, A. et al. TAB2 and TAB3 activate the NF-κB pathway through binding to polyubiquitin chains. Mol. Cell 15, 535–548 (2004).
Bloor, S. et al. Signal processing by its coil zipper domain activates IKKγ. Proc. Natl Acad. Sci. USA 105, 1279–1284 (2008).
Ea, C.-K., Deng, L., Xia, Z.-P., Pineda, G. & Chen, Z. J. Activation of IKK by TNFα requires site-specific ubiquitination of RIP1 and polyubiquitin binding by NEMO. Mol. Cell 22, 245–257 (2006).
Alam, S. L. et al. Ubiquitin interactions of NZF zinc fingers. EMBO J. 23, 1411–1421 (2004).
Kulathu, Y., Akutsu, M., Bremm, A., Hofmann, K. & Komander, D. Two-sided ubiquitin binding explains specificity of the TAB2 NZF domain. Nature Struct. Mol. Biol. 16, 1328–1330 (2009).
Sato, Y., Yoshikawa, A., Yamashita, M., Yamagata, A. & Fukai, S. Structural basis for specific recognition of Lys 63-linked polyubiquitin chains by NZF domains of TAB2 and TAB3. EMBO J. 28, 3903–3909 (2009).
Sato, Y. et al. Specific recognition of linear ubiquitin chains by the Npl4 zinc finger (NZF) domain of the HOIL-1L subunit of the linear ubiquitin chain assembly complex. Proc. Natl Acad. Sci. USA 108, 20520–20525 (2011).
Schröfelbauer, B., Polley, S., Behar, M., Ghosh, G. & Hoffmann, A. NEMO ensures signaling specificity of the pleiotropic IKKβ by directing its kinase activity toward IκBα. Mol. Cell 23 May 2012 (doi:10.1016/j.molcel.2012.04.020).
Rahighi, S. et al. Specific recognition of linear ubiquitin chains by NEMO is important for NF-κB activation. Cell 136, 1098–1109 (2009).
Yoshikawa, A. et al. Crystal structure of the NEMO ubiquitin-binding domain in complex with Lys 63-linked di-ubiquitin. FEBS Lett. 583, 3317–3322 (2009).
Hadian, K. et al. NF-κB essential modulator (NEMO) interaction with linear and Lys-63 ubiquitin chains contributes to NF-κB activation. J. Biol. Chem. 286, 26107–26117 (2011).
Cordier, F. et al. The zinc finger of NEMO is a functional ubiquitin-binding domain. J. Biol. Chem. 284, 2902–2907 (2009).
Laplantine, E. et al. NEMO specifically recognizes K63-linked poly-ubiquitin chains through a new bipartite ubiquitin-binding domain. EMBO J. 28, 2885–2895 (2009).
Ivins, F. J. et al. NEMO oligomerization and its ubiquitin-binding properties. Biochem. J. 421, 243–251 (2009).
Lo, Y.-C. et al. Structural basis for recognition of diubiquitins by NEMO. Mol. Cell 33, 602–615 (2009).
Tokunaga, F. et al. Involvement of linear polyubiquitylation of NEMO in NF-κB activation. Nature Cell Biol. 11, 123–132 (2009).
Niu, J., Shi, Y., Iwai, K. & Wu, Z.-H. LUBAC regulates NF-κB activation upon genotoxic stress by promoting linear ubiquitination of NEMO. EMBO J. 30, 3741–3753 (2011).
Arimoto, K. I. et al. Polyubiquitin conjugation to NEMO by triparite motif protein 23 (TRIM23) is critical in antiviral defense. Proc. Natl Acad. Sci. USA 107, 15856–15861 (2010).
Ashida, H. et al. A bacterial E3 ubiquitin ligase IpaH9.8 targets NEMO/IKKγ to dampen the host NF-κB-mediated inflammatory response. Nature Cell Biol. 12, 66–73 (2009).
Jura, N., Scotto-Lavino, E., Sobczyk, A. & Bar-Sagi, D. Differential modification of Ras proteins by ubiquitination. Mol. Cell 21, 679–687 (2006).
Pierce, N. W., Kleiger, G., Shan, S.-O. & Deshaies, R. J. Detection of sequential polyubiquitylation on a millisecond timescale. Nature 462, 615–619 (2009).
Thrower, J. S., Hoffman, L., Rechsteiner, M. & Pickart, C. M. Recognition of the polyubiquitin proteolytic signal. EMBO J. 19, 94–102 (2000).
Lasker, K. et al. Molecular architecture of the 26S proteasome holocomplex determined by an integrative approach. Proc. Natl Acad. Sci. USA 109, 1380–1387 (2012).
Zhang, D. et al. Together, Rpn10 and Dsk2 can serve as a polyubiquitin chain-length sensor. Mol. Cell 36, 1018–1033 (2009).
Schaefer, J. B. & Morgan, D. O. Protein-linked ubiquitin chain structure restricts activity of deubiquitinating enzymes. J. Biol. Chem. 286, 45186–45196 (2011). Demonstrates how ubiquitin chain length can alter DUB activity.
Finley, D. Recognition and processing of ubiquitin-protein conjugates by the proteasome. Annu. Rev. Biochem. 78, 477–513 (2009).
Yin, L., Krantz, B., Russell, N. S., Deshpande, S. & Wilkinson, K. D. Nonhydrolyzable diubiquitin analogues are inhibitors of ubiquitin conjugation and deconjugation. Biochemistry 39, 10001–10010 (2000).
Weikart, N. D. & Mootz, H. D. Generation of site-specific and enzymatically stable conjugates of recombinant proteins with ubiquitin-like modifiers by the CuI-catalyzed azide–alkyne cycloaddition. Chembiochem 11, 774–777 (2010).
Chatterjee, C., Mcginty, R. K., Fierz, B. & Muir, T. W. Disulfide-directed histone ubiquitylation reveals plasticity in hDot1L activation. Nature Chem. Biol. 6, 267–269 (2010).
Li, X., Fekner, T., Ottesen, J. J. & Chan, M. K. A pyrrolysine analogue for site-specific protein ubiquitination. Angew. Chem. Int. Ed. 48, 9184–9187 (2009).
Mcginty, R. K., Kim, J., Chatterjee, C., Roeder, R. G. & Muir, T. W. Chemically ubiquitylated histone H2B stimulates hDot1L-mediated intranucleosomal methylation. Nature 453, 812–816 (2008).
Chatterjee, C., Mcginty, R. K., Pellois, J.-P. & Muir, T. W. Auxiliary-mediated site-specific peptide ubiquitylation. Angew. Chem. Int. Ed. 46, 2814–2818 (2007).
Yang, R., Pasunooti, K. K., Li, F., Liu, X.-W. & Liu, C.-F. Synthesis of K48-linked diubiquitin using dual native chemical ligation at lysine. Chem. Commun. 46, 7199–7201 (2010).
Kumar, K. S. A., Spasser, L., Erlich, L. A., Bavikar, S. N. & Brik, A. Total chemical synthesis of di-ubiquitin chains. Angew. Chem. Int. Ed. 49, 9126–9131 (2010).
Oualid, El, F. et al. Chemical synthesis of ubiquitin, ubiquitin-based probes, and diubiquitin. Angew. Chem. Int. Ed. 49, 10149–10153 (2010).
Ajish Kumar, K. S., Haj-Yahya, M., Olschewski, D., Lashuel, H. A. & Brik, A. Highly efficient and chemoselective peptide ubiquitylation. Angew. Chem. Int. Ed. 48, 8090–8094 (2009).
Virdee, S. et al. Traceless and site-specific ubiquitination of recombinant proteins. J. Am. Chem. Soc. 133, 10708–10711 (2011).
Xu, P. & Peng, J. Dissecting the ubiquitin pathway by mass spectrometry. Biochim. Biophys. Acta 1764, 1940–1947 (2006).
Nielsen, M. L. et al. Iodoacetamide-induced artifact mimics ubiquitination in mass spectrometry. Nature Methods 5, 459–460 (2008).
Newton, K. et al. Ubiquitin chain editing revealed by polyubiquitin linkage-specific antibodies. Cell 134, 668–678 (2008).
Matsumoto, M. L. et al. Engineering and structural characterization of a linear-polyubiquitin-specific antibody. J. Mol. Biol. 418, 134–144 (2012).
Hjerpe, R. et al. Efficient protection and isolation of ubiquitylated proteins using tandem ubiquitin-binding entities. EMBO Rep. 10, 1250–1258 (2009).
Trempe, J.-F. et al. Mechanism of Lys48-linked polyubiquitin chain recognition by the Mud1 UBA domain. EMBO J. 24, 3178–3189 (2005).
Wiggins, C. M. et al. BIMEL, an intrinsically disordered protein, is degraded by 20S proteasomes in the absence of poly-ubiquitylation. J. Cell Sci. 124, 969–977 (2011).
Sims, J. J. et al. Polyubiquitin-sensor proteins reveal localization and linkage-type dependence of cellular ubiquitin signaling. Nature Methods 9, 303–309 (2012).
Keren-Kaplan, T. et al. Synthetic biology approach to reconstituting the ubiquitylation cascade in bacteria. EMBO J. 31, 378–390 (2012).
Vijay-Kumar, S., Bugg, C. E. & Cook, W. J. Structure of ubiquitin refined at 1.8Å resolution. J. Mol. Biol. 194, 531–544 (1987).
Xia, Z.-P. et al. Direct activation of protein kinases by unanchored polyubiquitin chains. Nature 461, 114–119 (2009).
Kirkpatrick, D. S. et al. Quantitative analysis of in vitro ubiquitinated cyclin B1 reveals complex chain topology. Nature Cell Biol. 8, 700–710 (2006).
Acknowledgements
The authors would like to thank their colleagues at the Medical Research Council (MRC) Laboratory of Molecular Biology for discussions and contributions to this Review, and apologize to authors whose work could not be cited due to space restrictions. Y.K. is supported by Marie Curie and EMBO long-term fellowships. D.K. is supported by the MRC (U105192732) and the EMBO Young Investigator Programme.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
David Komander is a consultant for Mission Therapeutics. Yogesh Kulathu declares no competing financial interests.
Related links
Glossary
- APC/C
-
(Anaphase promoting complex; also known as the cyclosome). A multi-subunit E3 ligase that targets proteins for proteasomal degradation. Substrates include many cell cycle proteins that need to be degraded during cell cycle progression.
- RING domain
-
Domain of approximately 70 amino acids with conserved Cys and His residues that coordinate two zinc ions. U-box domains share the RING fold but do not bind zinc.
- TEK box
-
A structural motif on the surface of ubiquitin that consists of Lys6, Lys11, Thr12, Thr14 and Glu34 and is required for UBE2C- and UBE2S-mediated assembly of Lys11-linked ubiquitin chains.
- Coiled coil
-
Structural motifs that are formed by amino acids arranged in a heptad repeat in which positions 1 and 4 of the repeat are hydrophobic amino acids (Ile, Leu or Val). These domains are present in many proteins and confer them with dimerization or oligomerization propensities.
- Cysteine proteases
-
Enzyme that use a nucleophilic Cys residue in the catalytic centre. The catalytic triad contains an adjacent His residue to deprotonate the Cys thiol and a polar residue to correctly position the His.
- Zinc metalloproteases
-
Proteases that have a zinc-binding motif in the catalytic centre to coordinate zinc. During catalysis the zinc promotes nucleophilic attack.
- p97
-
A hexameric AAA+ ATPase that exerts mechanical force on ubiquitylated cargo to, for example, dislocate proteins from membranes or disassemble complexes.
- Mitophagy
-
The selective degradation of mitochondria by autophagy.
Rights and permissions
About this article
Cite this article
Kulathu, Y., Komander, D. Atypical ubiquitylation — the unexplored world of polyubiquitin beyond Lys48 and Lys63 linkages. Nat Rev Mol Cell Biol 13, 508–523 (2012). https://doi.org/10.1038/nrm3394
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrm3394
This article is cited by
-
Vitamin B6 regulates IL-33 homeostasis to alleviate type 2 inflammation
Cellular & Molecular Immunology (2023)
-
Calpain activity is negatively regulated by a KCTD7–Cullin-3 complex via non-degradative ubiquitination
Cell Discovery (2023)
-
Peli3 ablation ameliorates acetaminophen-induced liver injury through inhibition of GSK3β phosphorylation and mitochondrial translocation
Experimental & Molecular Medicine (2023)
-
STUB1 directs FOXQ1-mediated transactivation of Ldha gene and facilitates lactate production in mouse Sertoli cells
Cell and Tissue Research (2023)
-
Lysine deserts prevent adventitious ubiquitylation of ubiquitin-proteasome components
Cellular and Molecular Life Sciences (2023)